Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Priority claimed from PCT/US2014/021130external-prioritypatent/WO2014138368A1/fr
Publication of MA38451A1publicationCriticalpatent/MA38451A1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
L'invention concerne des benzoimidazol-2-ylpyrimidines, leurs procédés de purification, des compositions pharmaceutiques et des méthodes de traitement d'états pathologiques, de troubles et de maladies médiés par l'activité du récepteur de h
MA38451A2013-03-062014-03-06Benzoimidazol-2-ylpyrimidines modulatrices du récepteur de l'histamine h4
MA38451A1
(fr)
3-замещенные производные эстра-1,3,5(10),16-тетраена, способы их получения, фармацевтические средства, которые их содержат, и их использование для получения лекарственных средств